Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Jurisson

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Bioconjugate Chemistry|November 10, 2018
NOTA and NODAGA [<sup>99m</sup>Tc]Tc- and [<sup>186</sup>Re]Re-Tricarbonyl Complexes: Radiochemistry and First Example of a [<sup>99m</sup>Tc]Tc-NODAGA Somatostatin Receptor-Targeting BioconjugateGeorge Makris, Lauren L Radford, Marina Kuchuk, et al.
Nuclear Medicine and Biology|February 7, 2006
Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesinMoustapha E Moustapha, Gary J Ehrhardt, Charles J Smith, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting propertiesJ Chen, Z Cheng, N K Owen, et al.
Nuclear Medicine and Biology|January 30, 2021
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, <sup>99m</sup>Tc and <sup>186</sup>Re metal centers: Radiochemistry and in vitro evaluationJing Wang, George Makris, Marina Kuchuk, et al.
Nuclear Medicine and Biology|May 3, 2011
Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivativesHeather M Bigott-Hennkens, Shorouk F Dannoon, Samantha M Noll, et al.
Nuclear Medicine and Biology|April 11, 2001
Development of an in vitro model for assessing the in vivo stability of lanthanide chelatesW P Li, D S Ma, C Higginbotham, et al.
Nuclear Medicine and Biology|March 22, 2008
99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptorStephanie R Lane, Bhadrasetty Veerendra, Tammy L Rold, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Chloro----hydroxy substitution on technetium BATO [TcCl(dioxime)3 BR] complexesS S Jurisson, W Hirth, K E Linder, et al.
Nuclear Medicine and Biology|January 3, 2017
Synthesis and evaluation of a <sup>99m</sup>Tc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumorsLauren Radford, Fabio Gallazzi, Lisa Watkinson, et al.
Plant Physiology and Biochemistry : PPB|March 17, 2017
In vivo transport of three radioactive [<sup>18</sup>F]-fluorinated deoxysucrose analogs by the maize sucrose transporter ZmSUT1Thu M Tran, Carissa S Hampton, Tom W Brossard, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Bioconjugate Chemistry|November 10, 2018
NOTA and NODAGA [<sup>99m</sup>Tc]Tc- and [<sup>186</sup>Re]Re-Tricarbonyl Complexes: Radiochemistry and First Example of a [<sup>99m</sup>Tc]Tc-NODAGA Somatostatin Receptor-Targeting BioconjugateGeorge Makris, Lauren L Radford, Marina Kuchuk, et al.
Nuclear Medicine and Biology|February 7, 2006
Preparation of cyclotron-produced 186Re and comparison with reactor-produced 186Re and generator-produced 188Re for the labeling of bombesinMoustapha E Moustapha, Gary J Ehrhardt, Charles J Smith, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 26, 2001
Evaluation of an (111)In-DOTA-rhenium cyclized alpha-MSH analog: a novel cyclic-peptide analog with improved tumor-targeting propertiesJ Chen, Z Cheng, N K Owen, et al.
Nuclear Medicine and Biology|January 30, 2021
Direct labeling of a somatostatin receptor antagonist via peptide cyclization with Re, <sup>99m</sup>Tc and <sup>186</sup>Re metal centers: Radiochemistry and in vitro evaluationJing Wang, George Makris, Marina Kuchuk, et al.
Nuclear Medicine and Biology|May 3, 2011
Labeling, stability and biodistribution studies of 99mTc-cyclized Tyr3-octreotate derivativesHeather M Bigott-Hennkens, Shorouk F Dannoon, Samantha M Noll, et al.
Nuclear Medicine and Biology|April 11, 2001
Development of an in vitro model for assessing the in vivo stability of lanthanide chelatesW P Li, D S Ma, C Higginbotham, et al.
Nuclear Medicine and Biology|March 22, 2008
99mTc(CO)3-DTMA bombesin conjugates having high affinity for the GRP receptorStephanie R Lane, Bhadrasetty Veerendra, Tammy L Rold, et al.
International Journal of Radiation Applications and Instrumentation. Part B, Nuclear Medicine and Biology|January 1, 1991
Chloro----hydroxy substitution on technetium BATO [TcCl(dioxime)3 BR] complexesS S Jurisson, W Hirth, K E Linder, et al.
Nuclear Medicine and Biology|January 3, 2017
Synthesis and evaluation of a <sup>99m</sup>Tc tricarbonyl-labeled somatostatin receptor-targeting antagonist peptide for imaging of neuroendocrine tumorsLauren Radford, Fabio Gallazzi, Lisa Watkinson, et al.
Plant Physiology and Biochemistry : PPB|March 17, 2017
In vivo transport of three radioactive [<sup>18</sup>F]-fluorinated deoxysucrose analogs by the maize sucrose transporter ZmSUT1Thu M Tran, Carissa S Hampton, Tom W Brossard, et al.
Pageof 9